RedHill Biopharma | RDHL - Current Assets

Stock Price
0.87
Daily Change
-0.01 -1.14%
Monthly
-14.71%
Yearly
-66.02%
Q1 Forecast
0.84

RedHill Biopharma reported $12.56M in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Cara Therapeutics USD 43.13M 4.18M Jun/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 88.92M 8.72M Sep/2025
Cronos Group USD 944.09M 21.94M Dec/2025
RedHill Biopharma USD 12.56M 644K Jun/2025